A PHASE I DOSE-ESCALATION STUDY OF MPEG-R-CRISANTASPASE ADMINISTERED BY INTRAVENOUS INFUSION IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGICAL MALIGNANCIES

被引:0
作者
Salles, G. [1 ]
Lepretre, S. [2 ]
Le Gouill, S. [3 ]
Rigal-Huguet, F. [4 ]
Haioun, C. [5 ]
Balouet, S. [6 ]
Corn, T. [7 ]
Thomas, X. [1 ]
机构
[1] Univ Lyon 1, Hosp Civils Lyon, Pierre Benite, France
[2] Ctr Henri Becquerel, F-76038 Rouen, France
[3] CHU Nantes, F-44035 Nantes 01, France
[4] Ctr Hosp Univ Toulouse, Toulouse, France
[5] Ctr Hosp Univ Henri Mondor, Creteil, France
[6] Lymphoma Acad Res Org LYSARC, Pierre Benite, France
[7] EUSA Pharma, Oxford, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P771
引用
收藏
页码:279 / 279
页数:1
相关论文
共 50 条
  • [21] Phase I dose-escalation, open-label study of HSP990 administered orally in adult patients with advanced solid malignancies.
    De Mattos-Arruda, Leticia
    Siu, Lillian L.
    Cortes, Javier
    Berge, Yann
    Razak, Albiruni R. A.
    Ahnert, Jordi Rodon
    Cottura, Ewa
    Bedard, Philippe
    Akimov, Mikhail
    Lu, Hong
    Pain, Scott
    Kaag, Audrey
    Delord, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
    Spreafico, A.
    Delord, J-P
    De Mattos-Arruda, L.
    Berge, Y.
    Rodon, J.
    Cottura, E.
    Bedard, P. L.
    Akimov, M.
    Lu, H.
    Pain, S.
    Kaag, A.
    Siu, L. L.
    Cortes, J.
    BRITISH JOURNAL OF CANCER, 2015, 112 (04) : 650 - 659
  • [23] A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
    A Spreafico
    J-P Delord
    L De Mattos-Arruda
    Y Berge
    J Rodon
    E Cottura
    P L Bedard
    M Akimov
    H Lu
    S Pain
    A Kaag
    L L Siu
    J Cortes
    British Journal of Cancer, 2015, 112 : 650 - 659
  • [24] A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors
    Sunil Sharma
    Joachim Beck
    Monica Mita
    Sofia Paul
    Margaret M. Woo
    Margaret Squier
    Brian Gadbaw
    H. Miles Prince
    Investigational New Drugs, 2013, 31 : 974 - 985
  • [25] A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors
    Sharma, Sunil
    Beck, Joachim
    Mita, Monica
    Paul, Sofia
    Woo, Margaret M.
    Squier, Margaret
    Gadbaw, Brian
    Prince, H. Miles
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 974 - 985
  • [26] iMATRIXcobi: A Phase I/II, Dose-Escalation Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of Cobimetinib in Paediatric and Young Adult Patients with Refractory/Relapsed Tumours
    Trippett, T.
    Simko, S.
    Ye, C.
    Caron, H.
    Geoerger, B.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S210 - S210
  • [27] Phase I dose escalation study of SR271425 administered as 24-hour intravenous continuous infusion in patients with refractory solid tumors
    de Braud, F
    Sessa, C
    Gallerani, E
    Curigliano, G
    Cipolla, C
    Columbo, A
    Gallino, A
    Schackleton, G
    Zilocchi, C
    Chadjaa, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 220S - 220S
  • [28] A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia
    Foster, Matthew C.
    Amin, Chirag
    Voorhees, Peter M.
    Van Deventer, Hendrik W.
    Richards, Kristy L.
    Ivanova, Anastasia
    Whitman, Jennifer
    Chiu, Wingkeung Michael
    Barr, Nathan D.
    Shea, Thomas
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1331 - 1337
  • [29] Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies
    Geoerger, Birgit
    Morland, Bruce
    Jimenez, Irene
    Frappaz, Didier
    Pearson, Andrew D. J.
    Vassal, Gilles
    Maeda, Patricia
    Kincaide, Jasmine
    Mueller, Udo
    Schlief, Sarah
    Teufel, Michael
    Ploeger, Bart A.
    Cleton, Adriaan
    Agostinho, Andrea C.
    V. Marshall, Lynley
    EUROPEAN JOURNAL OF CANCER, 2021, 153 : 142 - 152
  • [30] Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
    Richardson, Paul G.
    Weller, Edie
    Jagannath, Sundar
    Avigan, David E.
    Alsina, Melissa
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Ghobrial, Irene M.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    McKenney, Mary
    Delaney, Carol
    Mitsiades, Constantine S.
    Hideshima, Teru
    Dalton, William
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5713 - 5719